Topic: inflammatory conditions
Mutations in RIPK1 can cause uncontrolled cell death and inflammation, researchers discovered by studying families with an autoimmune disorder.
AnaptysBio's anti-IL-33 antibody did worse than placebo at easing eczema symptoms such as itch and skin inflammation after 16 weeks of treatment.
Scientists have discovered a scorpion toxin could inspire treatments to block the inflammation that triggers chronic pain.
Ritu Lal co-founded GEn1E alongside Clint Webb in 2018, licensing a group of p38alpha kinase inhibitors from the University of Maryland, Baltimore.
The termination of the clinical trial and molecule follows slower-than-expected progress for RG6174.
Immuno-oncology biotech Five Prime has outlicensed a medication from its protein discovery platform exclusively to Belgium biopharma UCB.
Evelo Biosciences has just forged closer ties with a heavyweight academic partner for its monoclonal microbials R&D, which envisages using bacteria to fight disease.
The study linked synthetic oral endocannabinoid-mimetic anabasum to a statistically significant drop on a skin disease scale.
The series D follows fast after InflaRx established the potential of its anti-human complement factor C5a monoclonal antibody IFX-1 with phase 2 data.
The multiyear agreement positions Lilly to work with Topas on drugs that convey tolerance to antigens linked to inflammation or autoimmune diseases.